#Avian Influenza Vaccines Market Analysis

[cmipooja]

Global Poultry Antibiotic Market Is Estimated To Witness High Growth Owing To Rising Concerns Regarding Poultry Health

The Global Poultry Antibiotic Market is estimated to be valued at US$ 3.45 billion in 2022 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Poultry Antibiotic Market refers to the market for antibiotics used in the poultry industry to prevent and treat various infections and diseases in poultry. Poultry antibiotics play a crucial role in ensuring the health and well-being of poultry, as they help in preventing and controlling diseases that can cause significant economic losses for poultry producers. Poultry antibiotics have several advantages, including improved feed conversion ratios, increased growth rates, enhanced disease resistance, and reduced mortality rates. These antibiotics help maintain the overall health of poultry and improve their productivity, thereby benefiting both the poultry industry and consumers. Market Key Trends: One key trend observed in the Poultry Antibiotic Market is the increasing demand for antibiotics derived from natural sources. As consumers are becoming more conscious about food safety and animal welfare, there is a growing preference for natural or organic products. This trend has led to the development and utilization of antibiotics derived from natural sources, such as plant extracts, essential oils, and probiotics. For example, companies like Zoetis Inc. and Elanco Animal Health are investing in research and development to develop antibiotics with natural origins. These antibiotics offer similar efficacy to synthetic antibiotics but are considered safer and more sustainable. PEST Analysis: - Political: Regulatory frameworks regarding the use of antibiotics in animal feed vary across different countries. Some countries have banned the use of certain antibiotics as growth promoters, while others have implemented stricter regulations on antibiotic use in animal husbandry. - Economic: The demand for poultry products is increasing globally, driven by population growth and rising disposable incomes. This creates a favorable market for poultry antibiotics as producers strive to meet the growing demand. - Social: Increasing concerns about food safety and animal welfare have led to a greater focus on reducing the use of antibiotics in animal feed. Consumers are becoming more conscious of the potential risks associated with antibiotic residues in poultry products. - Technological: Advancements in biotechnology and genetic engineering have paved the way for the development of alternative antibiotic strategies, such as vaccines and phage therapy. These technologies are expected to reduce the reliance on antibiotics in the future. Key Takeaways: Paragraph 1: The Global Poultry Antibiotic Market Size is expected to witness high growth, exhibiting a CAGR of 5.8% over the forecast period. This growth can be attributed to increasing concerns about poultry health and the need to prevent and treat diseases effectively. For example, outbreaks of avian influenza and other infectious diseases have highlighted the importance of proper disease management in the poultry industry. Paragraph 2: Asia-Pacific is expected to be the fastest-growing and dominating region in the Poultry Antibiotic Market. The region has a large population, increasing disposable incomes, and a growing demand for poultry products. Furthermore, countries like China and India have substantial poultry production and are investing in modern poultry farming practices, driving the demand for antibiotics.

[shradhacmi]

Global Poultry Vaccine Market is Estimated to Witness High Growth Owing to Increasing Poultry Diseases and Government Initiatives

The global poultry vaccine market is estimated to be valued at US$1,766.8 million in 2022 and is expected to exhibit a CAGR of 7.92% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Poultry vaccines are used to prevent and control various diseases in poultry. These vaccines stimulate the immune system of poultry, helping them develop immunity against specific diseases. Poultry vaccines are important for maintaining the health and productivity of poultry farms, as they prevent diseases that can cause high mortality rates and economic losses. These vaccines can be administered through different routes such as drinking water, injection, or spraying. Market Dynamics: Driver 1: Increasing Poultry Diseases The poultry industry is facing various diseases that can have significant economic impacts. Diseases like Newcastle disease, avian influenza, and infectious bursal disease (IBD) can cause high mortality rates, decreased egg production, and affect the overall growth and productivity of poultry farms. Vaccination plays a crucial role in preventing these diseases and maintaining the health and profitability of poultry farms. Driver 2: Government Initiatives Government initiatives promoting vaccination in the poultry industry are driving the growth of the poultry vaccine market. Governments across the world are implementing vaccination programs to control and prevent the spread of poultry diseases. For example, the United States Department of Agriculture (USDA) provides financial assistance to poultry farmers for the purchase of vaccines and vaccine administration. Such initiatives are encouraging poultry farmers to invest in vaccines, driving market growth. SWOT Analysis: Strength: 1. Effective Disease Prevention: Poultry Vaccine Market are highly effective in preventing and controlling various poultry diseases, ensuring the health and productivity of poultry farms. 2. Rising Demand: The increasing demand for poultry products worldwide is driving the demand for vaccines to maintain the health and productivity of poultry farms. Weakness: 1. High Storage and Handling Requirements: Poultry vaccines require specific storage and handling conditions, such as maintaining a cold chain, which can be challenging for some poultry farms. 2. Limited Accessibility in Remote Areas: Remote areas with limited infrastructure and accessibility may face challenges in accessing vaccines and implementing vaccination programs effectively. Opportunity: 1. Technological Advancements: Advancements in vaccine technology, such as new adjuvants and delivery systems, are creating opportunities for the development of more effective and efficient vaccines. 2. Emerging Markets: Increasing poultry production and rising awareness about disease prevention in emerging markets, such as India and China, present significant growth opportunities for the poultry vaccine market. Threats: 1. Stringent Regulatory Approval Process: The stringent regulatory approval process for vaccines can pose challenges for new market entrants. 2. Vaccine Safety Concerns: Safety concerns related to vaccine usage, such as adverse effects and potential vaccine failures, can impact market growth. Key Takeaways: The global poultry vaccine market is expected to witness high growth, exhibiting a CAGR of 7.92% over the forecast period, due to increasing poultry diseases and government initiatives promoting vaccination. North America is expected to dominate the market due to the presence of key players and a well-established poultry industry.

[esglatestmarketnews]

Poultry Vaccination—a Perusal of Diseases Control Measures Based on Regions and Countries

The high-density rearing of commercial birds has put the spotlight on poultry vaccination to boost immunity and protect against strains of pathogens. The prevalence of Newcastle diseases among turkeys, ducks, birds, geese and guinea fowl has prompted several countries to bolster their policies. In essence, Victoria, Australia, has made vaccination for Newcastle disease mandatory. Besides, pervasive antibiotic resistant salmonella strains in South Africa were reported in South Africa in 2022. The U.S., meanwhile, reported 57.53 million poultry animals grappling with high pathogenic avian influenza (HPAI), as of December 2022.

Grand View Research’s Animal Health Research Team has collated a qualitative and quantitative database with an emphasis on 3 key poultry diseases across 23 countries. The final report, coupled with the database, will deep-dive into the following dynamics:

• Estimated total poultry population with inputs on disease- status and –prevalence, reported new outbreaks, official vaccination and government regulations, among others.

• Insights on control measures, including general surveillance, border precaution, movement control and disease notification.

• Trends that could play an invaluable role in shaping the regional outlook, including North America, Europe and Asia Pacific.

• The database will also shed some light on government initiatives, vaccination status, disease status and reported new outbreaks.

Get your copy or request a free sample of the report “Poultry Vaccination Coverage Estimation By Diseases, 2018 – 2021,” compiled and published by Grand View Research.

Poultry Vaccination Coverage Report Scope

Species: Poultry

Region: North America, Europe, Asia Pacific, LATAM, MEA Country: U.S., Canada, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, Australia, Thailand, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Kuwait

Total Animal Population: Estimated Total Poultry Population from 2018 to 2021 (in numbers)

Disease Type: Newcastle Disease, Salmonella Sp., Avian Influenza-HPAI

Estimated Vaccination Coverage in %: Specifies the estimated percentage of animals that have received vaccination (at least one vaccine dose) for that particular disease. Includes both prophylactic and therapeutic vaccination.

Years: Quantitative Data 2018; 2019; 2020; 2021 Qualitative Data includes the 2022 updates

Notes: Specifies the relevant information on disease prevalence, disease active/non-active status, control measures, vaccination status (official/prohibited), reported new outbreaks for the years in scope, prevalent serotypes of viruses, recent disease situational updates, government initiatives, and others.

Deliverable Format: MS Excel/ Dashboard

Related Reports:

• Poultry Vaccines Market Size, Share & Trends Analysis Report By Product (Attenuated Live Vaccines, Inactivated Vaccines, Recombinant Vaccines), By Disease Type, By Application, By Region, And Segment Forecasts, 2023 – 2030

• ASEAN Poultry Vaccines Market Size, Share & Trends Analysis Report By Product (Attenuated Live Vaccines, Inactivated Vaccines, DNA Vaccines), By Application, By Disease, By Country, And Segment Forecasts, 2023 - 2030

About Us

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Find More information @ https://www.grandviewresearch.com/info/trend-reports

[the-rachana]

Avian Influenza Vaccines Market Size, Share, Economic Growth, Emerging Trends and Forecast till 2031

The report extensively examines the global Avian Influenza Vaccines market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Avian Influenza Vaccines. For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market for Avian Influenza Vaccines . We assist you with full and extensive research on the global Avian Influenza Vaccines Market using qualitative and quantitative analysis. Additionally, we concentrated on SWOT, PESTLE, and Porter's Five Forces assessments of the worldwide market for Avian Influenza Vaccines .

Get Sample Report With Graphs and Table @ https://www.growthplusreports.com/inquiry/request-sample/avian-influenza-vaccines-market/8566

Key Players Mentioned in the Global Avian Influenza Vaccines Market Research Report:

QianYuanHao Biological Corporation Limited

Bayer AG

Ringpu Bio-Technology Co., Ltd.

Harbin Veterinary Research Institute

Elanco

Zoetis Inc.

Eli Lilly and Company

FATRO S.p.A.

Johnson & Johnson Private Limited

Merck Animal Health

Boehringer Ingelheim GmbH

SEGMENTS

GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY TYPE

Combination Vaccines

Inactivated Vaccines

Live Recombinant Vaccines

GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY STRAIN

H5 Strain

H7 Strain

H9 Strain

GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY APPLICATION

Chicken

Turkey

Duck

Goose

Finding dominant companies in a specific Avian Influenza Vaccines industry is only one aspect of an analyst's role. To produce a thorough and comprehensive Avian Influenza Vaccines research study, analysts put out significant work, invest hours in research and analysis, compile unique information from market specialists, and draw on their own expertise and knowledge of the sector. One of a market research report's most crucial sections is the company profiling section since it offers players essential information they can use to improve their businesses or move them forward. In addition to identifying the leading companies in the global market for Avian Influenza Vaccines , this study also examines important facets of each company's operations and presents market growth estimates.

Avian Influenza Vaccines Market TOC: https://www.growthplusreports.com/report/toc/avian-influenza-vaccines-market/8566

Avian Influenza Vaccines Market: Regional analysis includes

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

For More Information or Query or Customization before buying, Visit at: https://www.growthplusreports.com/inquiry/customization/avian-influenza-vaccines-market/8566

Reasons to Buy This Report:

This file will help the peruses with appreciation the opposition interior the ventures and structures for the serious local weather to improve the feasible benefit. The document moreover facilities round the cutthroat scene of the market, and provides exhaustively the piece of the pie, industry positioning, contender organic system, market execution, new object advancement, recreation circumstance, development, and securing.

And so forth of the fundamental players, which assists the peruses with distinguishing the indispensable contenders and profoundly know the opposition instance of the market.

This record will help companions with greedy the global enterprise popularity and patterns of Avian Influenza Vaccines Administration Frameworks and offers them statistics on key market drivers, restrictions, difficulties, and open doors.

This document will aid companions with grasp contenders higher and collect experiences to reinforce their scenario in their organizations. The serious scene region contains the piece of the pie and rank (in extent and worth), contender environment, new object improvement, development, and obtaining.

This document stays refreshed with novel innovation mix, highlights, and the latest developments on the lookout.

This file assists companions with grasp the Coronavirus and Russia-Ukraine War Impact on the Avian Influenza Vaccines Administration Frameworks industry.

This record assists companions with obtaining bits of know-how into what locales to internationally target.

This file assists companions with obtaining experiences into the end-client perception regarding the reception of Avian Influenza Vaccines Administration Frameworks.

This document assists companions with distinguishing a component of the central members on the lookout and hold close their essential commitment.

Purchase this report now at 20% flat discount @ https://www.growthplusreports.com/checkout-8566

Visit our report store at - https://www.growthplusreports.com/report-store

Manan Sethi

Director, Market Insights

Email: sales@growthplusreports.com

256 Chapman Road

STE 105-4, Newark,

New Castle - 19702, USA

Phone no: +1 888 550 5009

Web: https://www.growthplusreports.com/

About US

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020."

[marketresearchreportinsight]

Avian Influenza Vaccines Market Research Key Players, Industry Overview, Supply Chain and Analysis 2028

Avian Influenza Vaccines Market Research Key Players, Industry Overview, Supply Chain and Analysis 2028

22 October 2019 – Global Avian Influenza Vaccines Marketis anticipated to witness significant growth in the forecast period due to rising prevalence of influenza due to unhealthy eating habits. Avian influenza is a disease (infection or flu) caused by avian bird. This infection is prevalent in aquatic birds and can infect the animal, poultry, and humans too. Avian influenza vaccination help…

[assetsstock-blog]

Global Avian Influenza Vaccines Market Trends, Drivers, Strategies, Applications and Competitive Landscape 2023

Global Avian Influenza Vaccines Market Trends, Drivers, Strategies, Applications and Competitive Landscape 2023

Global Avian Influenza Vaccines marketreport offers in-depth knowledge and analysis results and knowledge concerning Avian Influenza Vaccines drivers, restraints, opportunities, and trends valid by a mixture of specialists with correct data of the precise trade and Avian Influenza Vaccines market further as region-wise analysis experience. The Avian Influenza Vaccines report contains historical,…

[mrfrblogresearch02]

Animal Vaccines Market Report, Growth Insight, Deep Research & Segment Analysis 2027

Market Highlights

The global animal vaccines market is expected to have a market value of USD 13,209.14 million by 2027.

The animal vaccines market suffered immensely because pet owners and farmers were encouraged to keep their animals at home. They were advised against taking their pets to the vet to get strong and effective vaccines like the Pfizer veterinary vaccines. Growth in the veterinary/animal vaccines market is starting to pick up dramatically now that a vaccine for COVID-19 is being widely administered. Demand for animal vaccines is surging because livestock on farms around the world need these to remain healthy Segment Analysis

The global animal vaccines market is segmented into type, technology, and region. The type segment is further segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquacultutre vaccines. The technology segment is segmented into Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, others.

Regional Analysis

The global palliative care market, based on region, has been divided into Americas, Europe, Asia-Pacific, and Middle East & Africa.

Americas dominated the global animal vaccine market due to various factors, such as the rising prevalence of animal diseases and the rise in pet ownership in the region. Furthermore, the high number of veterinary clinics in the region also boosts the growth of the market. There is an increasing prevalence of animal diseases such as foot & mouth disease, canine parvovirus, distemper, and reproductive & respiratory syndrome. Parvovirus infections are seen across the US and Canada. The American Veterinary Medical Association (AVMA) reported around 118,624 veterinary practitioners were operating in 2020. Similarly, according to the statistics published by the Canadian Veterinary Medical Association in 2020, about 12,921 veterinarians were present in Canada.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7184

Europe accounted for a significant share in the market owing to a high population of companion animals in Europe, rising research and development investment, and increasing adoption of animal vaccines. According to the Industrial Association of Pet Care Producers, there are around 34 million pets in the UK, including dogs, cats, small mammals, and birds. In October 2021, Boehringer Ingelheim announced an additional 100 million EUR investment in its veterinary public health capabilities in Lyon-Jonage, France, to aid governments and public health organizations in managing future emerging and transboundary diseases. The additional investment will enable the adaptation of production lines for other emerging diseases, in particular swine and avian vaccines.

Asia-Pacific is expected to exhibit the highest CAGR during the forecast period of 2021-2027. This is due to lucrative opportunities for players operating in the animal vaccine market, a rise in the livestock population, and the increasing prevalence of animal diseases in the region. There is increasing awareness about animal health in the Asia-Pacific region. For instance, according to the report published by Pet Fair Asia and goumin.com, the total number of pet dogs and cats in China reached 99.15 million, with pet owners spending 29 billion US dollars in 2019. The increasing prevalence of animal diseases such as foot and mouth disease and avian influenza boosts the market growth in the region.

Middle East & Africa is expected to witness restricted growth compared to other regions due to limited access and healthcare affordability. The market growth in the region is driven by factors like the increasing incidence of zoonotic diseases and increasing pet adoption in the region. The common zoonotic disease diagnosed in this region is Rift Valley fever. Hence, emphasis is being put on promoting animal health in the region and improving healthcare services for companion animals.

Key Findings of the Study

The global animal vaccines market is estimated to reach USD 13,209.14 million by 2027 at a CAGR of 7.48 % during the assessment period.

Americas accounted for the largest share of the global animal vaccines market due to the rising prevalence of animal diseases and the rise in pet ownership in the region.

Based on type, the companion animal vaccines segment accounted for the largest market share of 42.2% in 2020.

By technology, the live attenuated vaccines segment accounted for the largest market share of 62.02% in 2020.

Some of the key players operating in the animal vaccines market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Ceva Santé Animale (France), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), Biogénesis Bagó S.A.(Argentina), Neogen Corporation (US).

Browse Detailed TOC with COVID-19 Impact Analysis at

https://www.marketresearchfuture.com/reports/animal-vaccines-market-7184

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[the-rachana]

Avian Influenza Vaccines Market Size, Share, Economic Growth, Emerging Trends and Forecast till 2031

The report extensively examines the global Avian Influenza Vaccines market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Avian Influenza Vaccines. For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market for Avian Influenza Vaccines . We assist you with full and extensive research on the global Avian Influenza Vaccines Market using qualitative and quantitative analysis. Additionally, we concentrated on SWOT, PESTLE, and Porter's Five Forces assessments of the worldwide market for Avian Influenza Vaccines .

Get Sample Report With Graphs and Table @ https://www.growthplusreports.com/inquiry/request-sample/avian-influenza-vaccines-market/8566

Key Players Mentioned in the Global Avian Influenza Vaccines Market Research Report:

QianYuanHao Biological Corporation Limited

Bayer AG

Ringpu Bio-Technology Co., Ltd.

Harbin Veterinary Research Institute

Elanco

Zoetis Inc.

Eli Lilly and Company

FATRO S.p.A.

Johnson & Johnson Private Limited

Merck Animal Health

Boehringer Ingelheim GmbH

SEGMENTS

GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY TYPE

Combination Vaccines

Inactivated Vaccines

Live Recombinant Vaccines

GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY STRAIN

H5 Strain

H7 Strain

H9 Strain

GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY APPLICATION

Chicken

Turkey

Duck

Goose

Finding dominant companies in a specific Avian Influenza Vaccines industry is only one aspect of an analyst's role. To produce a thorough and comprehensive Avian Influenza Vaccines research study, analysts put out significant work, invest hours in research and analysis, compile unique information from market specialists, and draw on their own expertise and knowledge of the sector. One of a market research report's most crucial sections is the company profiling section since it offers players essential information they can use to improve their businesses or move them forward. In addition to identifying the leading companies in the global market for Avian Influenza Vaccines , this study also examines important facets of each company's operations and presents market growth estimates.

Avian Influenza Vaccines Market TOC: https://www.growthplusreports.com/report/toc/avian-influenza-vaccines-market/8566

Avian Influenza Vaccines Market: Regional analysis includes

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

For More Information or Query or Customization before buying, Visit at: https://www.growthplusreports.com/inquiry/customization/avian-influenza-vaccines-market/8566

Reasons to Buy This Report:

This file will help the peruses with appreciation the opposition interior the ventures and structures for the serious local weather to improve the feasible benefit. The document moreover facilities round the cutthroat scene of the market, and provides exhaustively the piece of the pie, industry positioning, contender organic system, market execution, new object advancement, recreation circumstance, development, and securing.

And so forth of the fundamental players, which assists the peruses with distinguishing the indispensable contenders and profoundly know the opposition instance of the market.

This record will help companions with greedy the global enterprise popularity and patterns of Avian Influenza Vaccines Administration Frameworks and offers them statistics on key market drivers, restrictions, difficulties, and open doors.

This document will aid companions with grasp contenders higher and collect experiences to reinforce their scenario in their organizations. The serious scene region contains the piece of the pie and rank (in extent and worth), contender environment, new object improvement, development, and obtaining.

This document stays refreshed with novel innovation mix, highlights, and the latest developments on the lookout.

This file assists companions with grasp the Coronavirus and Russia-Ukraine War Impact on the Avian Influenza Vaccines Administration Frameworks industry.

This record assists companions with obtaining bits of know-how into what locales to internationally target.

This file assists companions with obtaining experiences into the end-client perception regarding the reception of Avian Influenza Vaccines Administration Frameworks.

This document assists companions with distinguishing a component of the central members on the lookout and hold close their essential commitment.

Purchase this report now at 20% flat discount @ https://www.growthplusreports.com/checkout-8566

Visit our report store at - https://www.growthplusreports.com/report-store

Manan Sethi

Director, Market Insights

Email: sales@growthplusreports.com

256 Chapman Road

STE 105-4, Newark,

New Castle - 19702, USA

Phone no: +1 888 550 5009

Web: https://www.growthplusreports.com/

About US

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020."

[healthcare-market]

Impact Assessment of COVID-19 Outbreak on Veterinary Vaccines Market

The research authors at Transparency Market Research have placed the evaluation of the global veterinary vaccines market at US$ 6,100 million in the year of 2017. They predict that the global veterinary vaccines market will grow at an exemplary CAGR of 6.5% over the forecast period of 2018 to 2026 and go on to hit the mark of US$ 12,000 million by the end of the forecast period in 2026. Rising spending on companion pet animals along with increasing prevalence of various animal diseases is expected to propel the growth of global veterinary vaccines market in coming years.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=215

Increasing prevalence of animal diseases such as rift valley fever and rotavirus, rising utilization of different types of animal vaccines, and increasing awareness regarding the availability of different types of vaccination programs in motivating the growth of the global veterinary vaccines market in coming years. Rising prevalence of avian influenza and foot and mouth disease, considered as two of the foremost trans barrier animal diseases have also fueled the requirement for enhanced products in the global veterinary vaccines market.

Request a Sample of Veterinary Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=215

DNA Vaccines Segment to Witness High Growth in Veterinary Vaccines Market in Near Future

Segments in the global veterinary vaccines market by technology include inactivated vaccines, live attenuated vaccines, conjugate vaccines, toxoid vaccines, and DNA Vaccines, among others. Live attenuated vaccines segment led the global veterinary vaccines market in recent years, however, this segment is projected to lose momentum owing to loss of opportunities for the new industry players in this particular segment. DNA vaccines segment may witness significant growth opportunities in the global veterinary vaccines market in coming years owing to their various advantages such as no need for adjuvants as well as no post vaccination reactions.

Segments in the global veterinary vaccines market by type of animal include companion animal vaccines and livestock animal vaccines. Livestock animal vaccines segments led the global veterinary vaccines market in 2017 but is anticipated to lose market share over the forecast period owing to decreasing number of farm animals in certain regions in the world. On the other hand, increasing number of companion animals along with rising expenditure on pet healthcare are expected to boost the segment in global veterinary vaccines market over the forecast period.

Request for Analysis of COVID19 Impact on Veterinary Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=215

North America Region Leads the Veterinary Vaccines Market

Key geographical regions covered in the professional intelligence report on the global veterinary vaccines market include North America (Canada and United States), Asia Pacific (including China, Japan, New Zealand, India, Australia, and rest of the Asia Pacific), Europe (including the United Kingdom, France, Spain, Italy, Germany, and rest of the Europe), Middle East and Africa (including South Africa, Gulf Cooperation Council countries, Israel, and rest of the Middle East and Africa), and Latin America (including Brazil, Mexico, and rest of the Latin America). Geographically, North America region held the largest share in the global veterinary vaccines market in 2017. This position in anticipated to remain in the forecast period, owing to rising ownership of companion animals and advanced vaccination programs in the region.

Enquiry before Buying Veterinary Vaccines Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=215

Players in the Veterinary Vaccines Market Expanding their Product Portfolios

Major corporate players covered in the market analysis on global veterinary vaccines market include Merck Animal Health, Eli Lilly and Company, Ceva Santé Animale, Biovac, ImmuCell Corporation, Boehringer Ingelheim GmbH, Zoetis, Inc., Bayer Animal health AG, Virbac, and Neogen Corporation. Manufacturers and players in the global veterinary vaccines market are adopting various inorganic as well as organic growth strategies to enhance their current product offerings and expand their product portfolios in order to gain a larger market share by expanding their consumer base as well as geographical reach. For example, Prondil S.A, an Uruguayan company was acquired by Merck Animal health in December of 2017 to design and produce more advanced livestock animal vaccines.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/human-microbiome-market-to-reach-us-2-2-bn-by-2028--states-tmr-report-301475663.html

https://www.prnewswire.com/news-releases/increase-in-prevalence-of-fascioliasis-to-help-triclabendazole-market-reach-us-632-1-mn-by-2031--notes-tmr-study-301478857.html

https://www.prnewswire.com/news-releases/medical-transcription-services-market-to-expand-at-cagr-of-5-during-forecast-period-observes-tmr-study-301482824.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[leftcomputerpost]

Middle East Veterinary Vaccines Market to Garner Brimming Revenues by 2026

Animal breeding remains to be one of the most fundamental agricultural activity facilitating the growth of food & beverage industry in the Middle East. Milk and meat are some of the common raw materials derived from animal husbandry activities carried out in the MEA region. Future Market Insights recently published its research report on the veterinary vaccines market in the Middle East, which stated that – rising demand for food security in the Middle East, collaborative manufacturing measures witnessed among foodmakers and suppliers, and the absence of appropriate health tracking facilities for animals are factoring the growth in demand for veterinary vaccines.

Future Market Insights projects that the MEA veterinary vaccines market, which is presently valued at US$ 267.3 million, will soar below average to reach US$ 422.9 million value by 2026-end and register a moderate CAGR of 4.7%. The report estimates that lack of resources for collection of samples, questionable potency of vaccines, and absence of harmonised vaccination procedures are limiting the supply and production of veterinary vaccines in the MEA region. Furthermore, ineffectiveness of veterinary vaccines in curing virulent animal diseases indicates shortcomings on epidemiological knowledge faced by MEA’s virology research institutes.

Highest Veterinary Vaccine Sales recorded in Jordan

A regional analysis of the veterinary vaccines market in the Middle East identified Jordan as the most lucrative country for sales of veterinary serums. By the end of 2026, Jordan’s veterinary vaccine market is expected to dominate the MEA region by reaching value of US$ 88 million. The demand for veterinary vaccines will be equally higher in Turkey, while Sudan will witness moderate growth in terms of revenues. Meanwhile, countries such as the United Arab Emirates, Kingdom of Saudi Arabia and Egypt will witness revenue growth at more than 4% CAGR throughout the forecast period.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3086

Based in Jordan, JOVAC is being recognised as one of the leading manufacturers of veterinary vaccines in the Middle East. The veterinary vaccines market in MEA region is also witnessing fervent involvement of European companies such as Bioveta, Inc., Merial, Bayer Healthcare AG, and Ceva. Other key players in the MEA veterinary vaccines market include, Intervac Pvt. Ltd., Zoetis, Elanco, and Merck & Co, Inc.

Surging Demand for Food & Mouth Disease Vaccination

Prevalence of oral and digestion-related disorders among animals is shaping up the growth in demand for veterinary vaccines across the Middle East. More than 25% of veterinary vaccines revenues amassed from the MEA region during the projection period will be accounted by food and mouth diseases. New Castle disease has also been observed as prominent indicator for administering veterinary vaccines in this region. Moreover, outbreak of Avian influenza in the MEA region is anticipated to attribute more than US$ 80 million revenues by 2026-end.

In the report, titled “Veterinary Vaccines Market: Middle East Industry Analysis and Opportunity Assessment, 2016-2026,” the demand for attenuated live vaccines is predicted to remain high throughout the forecast period. Inactivated vaccines will also gain traction, while revenues garnered from sales of recombinant vaccines, DNA vaccines and toxoid vaccines will grow at a sluggish CAGR. Almost three-fourth of gross revenues amassed from sales of veterinary vaccines in the Middle East will continue to be used for treatment of livestock animals. And, these vaccines are likely to enter the market through veterinary clinics and private veterinary pharmacies. Distribution of veterinary vaccines in the Middle East will also be carried out by hospitals, revenues from which are estimated to surpass US$ 100 million by the end of 2026.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-3086

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[wiseguy45]

Avian Influenza Vaccine  Marketresearch, Avian Influenza Vaccine  Marketreport, Avian Influenza Vaccine  Marketresearch report

[adityarana1687-blog]

Influenza Diagnostics Market Expected To Cross $3.3 Billion By 2024

The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.

Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has resulted in the lucrative growth of this segment with the fastest CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second highest market share following RIDTs, and this can be attributed to the fact that it provides detailed analytical results, sharper turnaround times, and high throughput.

Hospitals held the highest market share in 2015, but Point-of-Care Testing (POCT) is anticipated to overtake and lead the market in the coming future, owing to the increasing usage of POCT because of its ease of use and short turnaround times.

North America dominates the market, due to a high focus of the government and healthcare bodies to control influenza.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/influenza-diagnostics-market

Further Key Findings From the Study Suggest:

North America is anticipated to dominate the global influenza diagnostics market. The high adoption rates of in vitro diagnostics and presence of technologically advanced medical devices is expected to drive growth in the region.

The Asia Pacific region is anticipated to be the fastest growing region in the study period. This growth is attributed to factors such as increasing initiatives by the countries to counter the incidence of the disease. For instance, CDC reached a cooperative agreement with South-East Asian Region to fund non research-related bilateral influenza as a measure to respond to avian, seasonal, and pandemic influenza.

The RIDT segment is expected to grow at a significant rate compared to others and accounts for the largest share in 2015.

This market comprises several local as well as global players. Some of the major players of this vertical include Becton, Dickinson and Company, Roche Diagnostics, Alere, Quidel Corporation, and Thermo Fisher Scientific.

Grand View Research has segmented the influenza diagnostics market on the basis of test type, end use, and region:

Test Type Outlook (Revenue, USD Million, 2013 - 2024)

RIDTs

RT-PCR

Cell Culture

Others

End-use Outlook (Revenue, USD Million, 2013 - 2024)

Hospital

Point-of-Care Testing

Laboratories

Regional Outlook (Revenue, USD Million, 2013 - 2024)

North America

Europe

Asia Pacific

Latin America

MEA

U.S.

Canada

Germany

UK

China

India

Brazil

Mexico

South Africa

Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.